Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Dellinger

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Critical Care Medicine|January 15, 1998
Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study GroupR P Dellinger, J L Zimmerman, R W Taylor, et al.
Critical Care Medicine|December 1, 1990
Initial evaluation of human monoclonal anti-lipid A antibody (HA-1A) in patients with sepsis syndromeC J Fisher, J Zimmerman, M B Khazaeli, et al.
The New England Journal of Medicine|February 24, 1991
Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study GroupE J Ziegler, C J Fisher, C L Sprung, et al.
Intensive Care Medicine|January 31, 2013
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012R P Dellinger, Mitchell M Levy, Andrew Rhodes, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Critical Care Medicine|January 15, 1998
Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study GroupR P Dellinger, J L Zimmerman, R W Taylor, et al.
Critical Care Medicine|December 1, 1990
Initial evaluation of human monoclonal anti-lipid A antibody (HA-1A) in patients with sepsis syndromeC J Fisher, J Zimmerman, M B Khazaeli, et al.
The New England Journal of Medicine|February 24, 1991
Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study GroupE J Ziegler, C J Fisher, C L Sprung, et al.
Intensive Care Medicine|January 31, 2013
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012R P Dellinger, Mitchell M Levy, Andrew Rhodes, et al.
Pageof 7